Physician profile
Arfaat Khan
NPI 1538379144
$29,806.64
in general payments reported to CMS, 2019-2025
22 companies · $8,558 in 2025
The $8,558 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,010 · 2020: $1,874 · 2021: $2,247 · 2022: $7,078 · 2023: $3,242 · 2024: $3,798 · 2025: $8,558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,361 · Travel and Lodging: $5,041 · Consulting Fee: $4,125 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,361.40 |
| Travel and Lodging | $5,040.82 |
| Consulting Fee | $4,125.00 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $8,229.04 | 2019-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Abbott Laboratories | $5,613.49 | 2019-2025 | Aveir, Jot Dx |
| Medtronic, INC. | $5,508.36 | 2021-2025 | Cobalt Dr Mri Surescan, Micra, Arctic Front Advance |
| Medtronic Vascular, INC. | $3,985.51 | 2019-2020 | |
| Boston Scientific Corporation | $3,046.39 | 2019-2025 | Watchman Flx, Watchman Access System, Farapulse |
| Medical Device Business Services, INC. | $1,096.78 | 2022 | |
| Biotronik INC. | $414.78 | 2019-2025 | Selectra |
| Philips North America LLC | $297.83 | 2020-2024 | (9520) Igt Devices Undivided, (O49) Image Guided Therapy Und |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $290.82 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $235.46 | 2019-2022 | |
| Kestra Medical Technology Services, INC. | $230.87 | 2023-2024 | Assure Wcd |
| Abiomed | $184.24 | 2024-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $144.86 | 2024-2025 | Wainua |
| Terumo Medical Corporation | $125.00 | 2023 | Azur Cx Detachable |
| Pfizer INC. | $111.72 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiofocus, INC. | $110.75 | 2021 | |
| Cordis US Corp. | $66.32 | 2024-2025 | Mynx Control Venous, Mynx Control |
| Bridgebio Pharma, INC. | $31.99 | 2025 | Attruby |
| Cardiva Medical, INC. | $31.46 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Bardy Diagnostics, INC. | $20.00 | 2019 | |
| Chiesi USA, INC. | $17.54 | 2024 | Kengreal, Cleviprex |
| Stereotaxis INC | $13.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arfaat Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.